BioTrends Newsletter
Bjarke Bak Christensen
Bjarke Bak Christensen, Head of DTU Bioengineering.
DTU’s new National Biologics Facility (NBF) brings DTU into the world league of CHO cell line engineering. Faster development of biological drugs and treatments is one of the goals of NBF, and the facility will benefit small and medium-sized enterprises, as they can to draw on our services in their work with identifying and developing new drug candidates.
From DTU’s point of view, it is also wonderful that NBF is making it possible to establish new study programmes within CHO cell line engineering.


Danish research into cell cultures and the development of proteins for biological pharmaceuticals—including for cancer treatment—is strengthened with new unit at DTU. Read more
A new study shows that gut bacteria play a greater role in weight loss than diet and genetics combined. Read more
The facility is a major step on the road to targeted use of microbiomes for biological control of disease-causing organisms. Read more
The newly formed cluster will contribute to and improve the foundation for world-class patient care, innovation and product development. Read more
A grant of DKK 25 M from Wellcome gives hope to snakebite victims in sub-Saharan Africa of better and safer treatment. Read more
Researchers have now mapped how coliform bacteria attach to the intestinal wall giving hope for development of new treatments. Read more
Job Postings
Job Postings
DTU Bioengineering
DTU Bioengineering - Department of Biotechnology and Biomedicine
The department adresses important social and scientific challenges within biotechnology, biomedicine, food technology and human and animal health. 

DTU Bioengineering

Søltofts Plads
Building 221
DK-2800 Kgs. Lyngby
Phone +45 45 25 26 00
E-mail: info@bio.dtu.dk
CVR-nr. 30060946
EAN-nr. 5798000430273 
P-nr. 1003403265 
PIC-nummer 999990655

Privacy Policy


Follow us on
Twitter Facebook YouTube LinkedIn

Unsubscribe/edit newsletter
See newsletter online